Trial
NCT04648020
Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Monopar Therapeutics
Collaborators
—
Condition
Chemoradiotherapy-Induced Severe Oral Mucositis
Intervention
Clonidine HCl Mucoadhesive Buccal Tablet
Why stopped
Interim Analysis did not meet the pre-defined threshold for efficacy of a 15% absolute difference in SOM prevention between Validive and placebo.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-31